| Irina Vancea, MD | |
|
3426 Lake Ave, Ste 120, Pueblo, CO 81004-3877 | |
| (719) 561-5264 | |
| (719) 561-5272 |
| Full Name | Irina Vancea |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 16 Years |
| Location | 3426 Lake Ave, Pueblo, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205919750 | NPI | - | NPPES |
| 08252866 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 46605 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pueblo West Dialysis (fmc) | Pueblo west, CO | Dialysis facility |
| Walsenburg Dialysis (fmc) | Walsenburg, CO | Dialysis facility |
| La Junta Dialysis (fmc) | La junta, CO | Dialysis facility |
| Pueblo Dialysis (fmc) | Pueblo, CO | Dialysis facility |
| Parkview Medical Center, Inc | Pueblo, CO | Hospital |
| St Mary Corwin Med Ctr, Centura Health | Pueblo, CO | Hospital |
| Arkansas Valley Regional Medical Center | La junta, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern Colorado Nephrology Assoc Pc | 5395636161 | 8 |
News Archive
Celgene Corporation announced non-GAAP (Generally Accepted Accounting Principles) net income of $290.3 million, or non-GAAP diluted earnings per share of $0.62 for the quarter ended December 31, 2009. Non-GAAP net income for the fourth quarter of 2008 was $200.9 million or non-GAAP diluted earnings per share of $0.43. Based on U.S. GAAP, Celgene reported net income of $254.2 million, or diluted earnings per share of $0.54 for the quarter ended December 31, 2009. GAAP net loss for the fourth quarter of 2008 was $149.3 million, or diluted loss per share of $0.33.
The CDC is investigating a series of cases of mysterious, severe lung disease. The cause is not known, but every patient uses an e-cigarette.
An anticancer drug that is commonly used to treat lung and colon malignancies is having a benefit and potentially prolonging survival in patients with invasive bladder cancer, researchers reported at the 2009 Clinical Congress of the American College of Surgeons.
Zeta Instruments, Inc. a leading provider of cost-effective, precision measurement solutions for micron-scale surface analysis, announced that its Zeta-20™ optical metrology system has been selected for the analysis and development of advanced microfluidics/biotechnology laboratory products. IntegenX, an innovative supplier of automation systems for DNA and RNA-based micro-sample preparation used in forensics and gene sequencing, has chosen Zeta's 3D surface measurement solution to analyze the dimensional properties of its micro-channel biochips.
› Verified 1 days ago
| Entity Name | Southern Colorado Nephrology Assoc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083642144 PECOS PAC ID: 5395636161 Enrollment ID: O20040322001284 |
News Archive
Celgene Corporation announced non-GAAP (Generally Accepted Accounting Principles) net income of $290.3 million, or non-GAAP diluted earnings per share of $0.62 for the quarter ended December 31, 2009. Non-GAAP net income for the fourth quarter of 2008 was $200.9 million or non-GAAP diluted earnings per share of $0.43. Based on U.S. GAAP, Celgene reported net income of $254.2 million, or diluted earnings per share of $0.54 for the quarter ended December 31, 2009. GAAP net loss for the fourth quarter of 2008 was $149.3 million, or diluted loss per share of $0.33.
The CDC is investigating a series of cases of mysterious, severe lung disease. The cause is not known, but every patient uses an e-cigarette.
An anticancer drug that is commonly used to treat lung and colon malignancies is having a benefit and potentially prolonging survival in patients with invasive bladder cancer, researchers reported at the 2009 Clinical Congress of the American College of Surgeons.
Zeta Instruments, Inc. a leading provider of cost-effective, precision measurement solutions for micron-scale surface analysis, announced that its Zeta-20™ optical metrology system has been selected for the analysis and development of advanced microfluidics/biotechnology laboratory products. IntegenX, an innovative supplier of automation systems for DNA and RNA-based micro-sample preparation used in forensics and gene sequencing, has chosen Zeta's 3D surface measurement solution to analyze the dimensional properties of its micro-channel biochips.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Irina Vancea, MD 3426 Lake Ave, Ste 120, Pueblo, CO 81004-3877 Ph: () - | Irina Vancea, MD 3426 Lake Ave, Ste 120, Pueblo, CO 81004-3877 Ph: (719) 561-5264 |
News Archive
Celgene Corporation announced non-GAAP (Generally Accepted Accounting Principles) net income of $290.3 million, or non-GAAP diluted earnings per share of $0.62 for the quarter ended December 31, 2009. Non-GAAP net income for the fourth quarter of 2008 was $200.9 million or non-GAAP diluted earnings per share of $0.43. Based on U.S. GAAP, Celgene reported net income of $254.2 million, or diluted earnings per share of $0.54 for the quarter ended December 31, 2009. GAAP net loss for the fourth quarter of 2008 was $149.3 million, or diluted loss per share of $0.33.
The CDC is investigating a series of cases of mysterious, severe lung disease. The cause is not known, but every patient uses an e-cigarette.
An anticancer drug that is commonly used to treat lung and colon malignancies is having a benefit and potentially prolonging survival in patients with invasive bladder cancer, researchers reported at the 2009 Clinical Congress of the American College of Surgeons.
Zeta Instruments, Inc. a leading provider of cost-effective, precision measurement solutions for micron-scale surface analysis, announced that its Zeta-20™ optical metrology system has been selected for the analysis and development of advanced microfluidics/biotechnology laboratory products. IntegenX, an innovative supplier of automation systems for DNA and RNA-based micro-sample preparation used in forensics and gene sequencing, has chosen Zeta's 3D surface measurement solution to analyze the dimensional properties of its micro-channel biochips.
› Verified 1 days ago
Dr. Christopher John Calcagno, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1600 N. Grand Ave., Ste. 300, Pueblo, CO 81003 Phone: 719-562-2001 Fax: 719-562-2742 | |
Christopher Jon Stark, Nephrology Medicare: Medicare Enrolled Practice Location: 400 W 16th St, Pueblo, CO 81003 Phone: 719-595-2218 Fax: 719-595-7994 | |
Greg Alan Bowman, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1600 N Grand Ave, Suite 500, Pueblo, CO 81003 Phone: 719-545-0663 Fax: 719-595-7903 | |
Lauren E. Sullenberger, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 902 Lakeview Ave, Pueblo, CO 81004 Phone: 719-557-5855 Fax: 719-557-5097 | |
Peter Lochow, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3670 Parker Blvd Ste 101, Pueblo, CO 81008 Phone: 719-564-1544 Fax: 719-924-1593 | |
Dr. Raj Vashistha, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3670 Parker Blvd., Ste 101, Pueblo, CO 81008 Phone: 719-564-1544 Fax: 719-924-1592 | |
Dr. Rebecca Elizabeth Holder, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1207 Pueblo Boulevard Way, Pueblo, CO 81005 Phone: 719-542-0032 Fax: 719-553-1904 |